Skip to content

D&A at other companies

Onto Innovation logo
Onto InnovationONTO
$5.78M+31.6%
Nordson logo
NordsonNDSN
$36.32M-3.4%
Globus Medical logo
Globus MedicalGMED
$69.86M+6.4%
Belden logo
BeldenBDC
$32.46M+9.0%
Regal Rexnord logo
Regal RexnordRRX
$37.3M-7.0%
ROP
Roper Technologies, Inc.ROP
$10M+9.9%

Segments

By segment

See full
Medical Solutions$9.58M+24.7%
Automation Enabling Technologies$4.2M-23.3%

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's D&A?
Novanta (NOVT) reported D&A of $14.16M in Q1 2026.
How has Novanta's D&A changed year-over-year?
Novanta's D&A increased by 4.4% year-over-year, from $13.56M to $14.16M.
What is the long-term trend for Novanta's D&A?
Over 4 years (2021 to 2025), Novanta's D&A has grown at a 9.3% compound annual growth rate (CAGR), from $43.39M to $61.93M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.